-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on VolitionRX, Lowers Price Target to $3

Benzinga·12/18/2025 12:23:15
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $5 to $3.